golodirsen
Generic: GOLODIRSEN·Brand: VYONDYS 53, Vyondys 53
golodirsen: 1 clinical trial tracked.
golodirsen evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about golodirsen, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
A Long-term Observational Study Evaluating Sarepta Therapeutics, Inc.'s Exon-Skipping Therapies in Patients With Duchenne Muscular Dystrophy Under Conditions of Routine Clinical Practice
Primary endpoint: Loss of Ambulation (LOA)
Observational300 targetStarted 2019-01Completion 2033-1220 sites · United StatesSarepta Therapeutics, Inc.